Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0686 | 0.8265 | 0.8265 |
Echinococcus multilocularis | protein patched | 0.034 | 0.399 | 0.399 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0023 | 0.0068 | 0.0068 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0017 | 0 | 0.5 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0388 | 0.4577 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 0.399 | 0.399 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0023 | 0.0068 | 0.0149 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.034 | 0.399 | 0.399 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0826 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Echinococcus granulosus | acetylcholinesterase | 0.0135 | 0.146 | 0.146 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Echinococcus multilocularis | acetylcholinesterase | 0.0135 | 0.146 | 0.146 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0071 | 0.0668 | 0.0668 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0017 | 0 | 0.5 |
Entamoeba histolytica | Pten 3-phosphoinositide phosphatase, putative | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0135 | 0.146 | 0.146 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0135 | 0.146 | 0.146 |
Loa Loa (eye worm) | carboxylesterase | 0.0023 | 0.0068 | 0.0068 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0826 | 1 | 1 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0826 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0686 | 0.8265 | 0.8265 |
Brugia malayi | CHE-14 protein | 0.034 | 0.399 | 0.399 |
Echinococcus granulosus | neuroligin | 0.0023 | 0.0068 | 0.0068 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0826 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0135 | 0.146 | 0.146 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034 | 0.399 | 0.8718 |
Brugia malayi | Carboxylesterase family protein | 0.0023 | 0.0068 | 0.0068 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0023 | 0.0068 | 0.5 |
Onchocerca volvulus | 0.0023 | 0.0068 | 1 | |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0388 | 0.4577 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0135 | 0.146 | 0.146 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Brugia malayi | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Schistosoma mansoni | gliotactin | 0.0023 | 0.0068 | 0.0068 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0686 | 0.8265 | 0.8265 |
Brugia malayi | Carboxylesterase family protein | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.034 | 0.399 | 0.399 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0023 | 0.0068 | 0.0149 |
Brugia malayi | Carboxylesterase family protein | 0.0135 | 0.146 | 0.146 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0023 | 0.0068 | 0.0068 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0826 | 1 | 1 |
Onchocerca volvulus | 0.0023 | 0.0068 | 1 | |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.0826 | 1 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.0135 | 0.146 | 0.146 |
Loa Loa (eye worm) | carboxylesterase | 0.0135 | 0.146 | 0.146 |
Onchocerca volvulus | 0.0023 | 0.0068 | 1 | |
Schistosoma mansoni | acetylcholinesterase | 0.0023 | 0.0068 | 0.0068 |
Echinococcus multilocularis | acetylcholinesterase | 0.0135 | 0.146 | 0.146 |
Brugia malayi | Carboxylesterase family protein | 0.0023 | 0.0068 | 0.0068 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0686 | 0.8265 | 0.8265 |
Schistosoma mansoni | patched 1 | 0.034 | 0.399 | 0.399 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0023 | 0.0068 | 0.5 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0071 | 0.0668 | 0.0668 |
Brugia malayi | Carboxylesterase family protein | 0.0135 | 0.146 | 0.146 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.0826 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0388 | 0.4577 | 1 |
Onchocerca volvulus | 0.0023 | 0.0068 | 1 | |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Onchocerca volvulus | 0.0023 | 0.0068 | 1 | |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.034 | 0.399 | 0.399 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0686 | 0.8265 | 0.8265 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.034 | 0.399 | 0.399 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0826 | 1 | 1 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.034 | 0.399 | 0.399 |
Echinococcus multilocularis | neuroligin | 0.0023 | 0.0068 | 0.0068 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0388 | 0.4577 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0023 | 0.0068 | 0.0068 |
Brugia malayi | Carboxylesterase family protein | 0.0023 | 0.0068 | 0.0068 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0135 | 0.146 | 0.146 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0826 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0135 | 0.146 | 0.146 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0023 | 0.0068 | 0.0068 |
Echinococcus granulosus | Protein patched homolog 1 | 0.034 | 0.399 | 0.399 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0023 | 0.0068 | 0.0068 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.034 | 0.399 | 0.399 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0023 | 0.0068 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0068 | 0.0068 |
Echinococcus multilocularis | protein dispatched 1 | 0.034 | 0.399 | 0.399 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 13.07 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 5 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 13.07 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 0.5 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 13.95 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 3 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 14.9 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 4 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 15.46 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 1 hr | ChEMBL. | 18829331 |
Activity (functional) | = 16.27 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 0.5 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 16.78 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 100 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 2 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 20.18 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 5 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 20.95 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 1 hr | ChEMBL. | 18829331 |
Activity (functional) | = 21.51 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 2 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 21.84 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 3 hrs | ChEMBL. | 18829331 |
Activity (functional) | = 21.85 % | Antiinflammatory activity against carrageenan-induced paw edema in ICR mouse at 50 mg/kg, ip administered 30 mins before carrageenan challenge assessed after 4 hrs | ChEMBL. | 18829331 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.